ES71
TEAS SECTION 71 RECEIVED
07/16/2026
Back to search
Official data from USPTO
BIOLUMI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
07/16/2026
Trademark type
Combined
Nice classes
5, 10
Filing date
07/08/2015
Registration date
09/27/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/19/2022
Last transaction
07/16/2026
Responsible office
United States Patent and Trademark Office
Status code
707
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
Shenzhen, Guangdong, CN
Examiner
SEVERSON, KAREN
Law office
M80
Mark description
The mark consists of wording "BIOLUMI" in stylized font.
Holders and representatives
Holders
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Representatives
Stacy L. Emhoff Walker & Jocke Co., LPA
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Drugs for medical purposes for treatment of tumorsthyroid diseaseglycometabolism diseasebone metabolic diseasegonad diseasekidney diseasecardiovascular diseasehepatic fibrosisanemiainflammation diseaseshepatitis diseaseEpstein-Barr (EB) viruseshormonal diseasesTORCH infections and immunoglobulin disease; chemical preparations for the diagnosis of pregnancy; Medicated serums for invitro diagnosis of pregnancy and treatment of blood conditions during pregnancy; Serotherapeutic medicines for the treatment of hepatitis; cultures of microorganisms for medical and veterinary use; biological preparations for pharmaceutical purposes for treatment of tumorsthyroid diseaseglycometabolism diseasebone metabolic diseasegonad diseasekidney diseasecardiovascular diseasehepatic fibrosisanemiainflammation diseaseshepatitis diseaseEpstein-Barr (EB) viruseshormonal diseasesTORCH infections and immunoglobulin diseases; Chemical preparations for pharmaceutical purposesfor diagnosis or treatment of tumorsthyroid diseaseglycometabolism diseasebone metabolic diseasegonad diseasekidney diseasecardiovascular diseasehepatic fibrosisanemiainflammation diseaseshepatitis diseaseEpstein-Barr (EB) viruseshormonal diseasesTORCH infections and immunoglobulin diseases; Diagnostic preparations for medical purposesfor diagnosing or detecting tumorsthyroid diseaseglycometabolism diseasebone metabolic diseasegonad diseasekidney diseasecardiovascular diseasehepatic fibrosisanemiainflammation diseaseshepatitis diseaseEpstein-Barr (EB) viruseshormonal diseasesTORCH infections and immunoglobulin diseases; enzymes for medical purposes; enzyme preparations for medical purposes
Class 10
Blood testing apparatus; massage apparatus; Testing apparatus for medical purposesmedical testing instrument for testing blood samplesbody fluids and body tissue samples; Apparatus for use in medical analysismedical analyzer for analysis of blood samplesbody fluids and body tissue samples;Diagnostic apparatus for medical purposesmedical diagnostic analyzer for analyzing blood samplesbody fluids and body tissue samples; radiotherapy apparatus; Ultrasonic devices for medical useclinical ultrasonic diagnostic apparatus; artificial limbs; Multifunction corsets for medical purposediagnosis and therapeutic corsets for medical purpose; suture materials
Publications
History of USPTO decisions and trademark events.
45 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/02/2026
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
09/27/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
07/10/2025
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
04/18/2023
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
03/13/2023
XXCR
GENERIC MADRID TRANSACTION CREATED
03/13/2023
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
01/19/2023
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
05/19/2022
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
05/19/2022
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
05/10/2022
PR71
POST REGISTRATION ACTION MAILED - SEC.71
04/30/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/27/2022
ES71
TEAS SECTION 71 RECEIVED
09/27/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/20/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/23/2017
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
12/29/2016
XXCR
GENERIC MADRID TRANSACTION CREATED
12/29/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/27/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
09/27/2016
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/15/2016
PUBO
PUBLISHED FOR OPPOSITION
07/12/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/22/2016
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/22/2016
NPUB
NOTICE OF PUBLICATION
06/22/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/09/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/02/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/01/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/01/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/01/2016
CNRT
NON-FINAL ACTION MAILED
01/27/2016
CNRT
NON-FINAL ACTION WRITTEN
01/27/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/25/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/25/2016
ALIE
ASSIGNED TO LIE
01/22/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/10/2016
RFNT
REFUSAL PROCESSED BY IB
01/05/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/16/2015
RFRR
REFUSAL PROCESSED BY MPU
12/16/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/15/2015
MAFR
APPLICATION FILING RECEIPT MAILED
12/15/2015
CNRT
NON-FINAL ACTION WRITTEN
12/14/2015
DOCK
ASSIGNED TO EXAMINER
12/11/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/11/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/10/2015
Continuous trademark protection
Get notified about every new filing that threatens BIOLUMI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.